The GLP-1 Effect: Prescription Drugs Go Direct-to-Consumer

October 14, 2026
Consumer Centric Care
Increasingly prescribed through telehealth and direct-to-consumer platforms, GLP-1 therapies are reshaping norms around access to prescription medicines. Surging consumer demand around these innovative therapies accelerated new access models, offering a blueprint for how patient demand can reshape drug distribution and the future of pharmaceutical delivery.